Latest Industry Projects

Apotex to Invest $184 Million for Expansion of R&D, Manufacturing, and Packaging Facility in United States

Apotex to Invest $184 Million for Expansion of R&D, Manufacturing, and Packaging Facility in United States

Introduction:

Apotex Inc., the largest Canadian owned pharmaceutical company plans $184 million U.S. expansion plan, including the development of a new R&D center and advanced manufacturing and packaging facility that will serve as the U.S. headquarters for Apotex Corp. and the U.S. offices for Apobiologix.

Features:

The company chose this strategic location to facilitate more efficient expansion and service of the critical U.S. market, to enhance access to Latin America, and to capture the benefits of Broward County's business environment. When completed, this facility – located in Miramar, FL – will be one of the largest manufacturing projects in South Florida. The site will also house the packaging operations of Aveva Drug Delivery Systems.

Construction on the building is underway and expected to be completed in early 2019. This move marks the largest investment that Apotex has made in the U.S. and will result in at least 150 new full-time positions.

With generic and biosimilar medicines playing an increasingly vital role in reducing the cost of drugs, Apotex will continue making strategic investments in R&D and American manufacturing to deliver high-quality, affordable medicine to patients, healthcare providers and stakeholders in the U.S. and around the world. In addition, due to U.S. regulations, we are only permitted to manufacture controlled substances in the U.S. when serving this market, so expansion in Canada was not feasible, said Apotex CEO and President, Dr. Jeremy B. Desai.

Specifications:

Company Name Apotex Inc.,
Location United States
Type Expansion
Estimated Cost $184 Million
Jobs 150 New Jobs

 

Source: apotex.com

Other Projects